Expected news in the approximately the next month are as follows MDR approval Approx $1.1 million R & D tax refund Possibly further sites using the Oncosil Regulatory clearance in Saudi Arabia and South Korea. Ansto contract negotiations were completed in October, 2024 and the Ansto Agreement will be signed this month.
Good to see a new addition to the team in Spain with strong sales experience in this sector , elaborating and executing the commercial plan to fulfill the assigned objectives in public and private hospitals/clinics working on public tenders. Currently 12 sites using Oncosil in Spain so this could be a good move if they get the monthly sales revenue moving much stronger with momentum in Spain as well as other countries.
OSL Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)